Author： Stahlmann R.
Publisher： Adis International
ISSN： 1170-229X
Source： Drugs & Aging, Vol.20, Iss.4, 2003-01, pp. : 289-302
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Safety Considerations of Fluoroquinolones in the Elderly: An Update
By Stahlmann Ralf Lode Hartmut
Drugs & Aging, Vol. 27, Iss. 3, 2010-03 ,pp. :
Access to resources
Recommend
Treating Epilepsy in the Elderly: Safety Considerations
By Arroyo S.
Drug Safety, Vol. 24, Iss. 13, 2001-01 ,pp. :
Safety of fluoroquinolones in paediatrics
By Cuzzolin Laura Fanos Vassilios
Expert Opinion on Drug Safety, Vol. 1, Iss. 4, 2002-11 ,pp. :
Treatment of Chronic Non-Malignant Pain in the Elderly: Safety Considerations
Drug Safety, Vol. 32, Iss. 6, 2009-05 ,pp. :